The conclusions of the experimentation are expected by the end of 2017. Beyond this partnership, DOSIsoft pursues its scientific collaborations with UNICANCER and all CLCCs for further improving patient care in radiation therapy.
About DOSIsoft
Founded in 2002, DOSIsoft develops cutting-edge software solutions for Radiation Oncology and Nuclear Medicine. 15 years of innovation and R&D investments have led to world leading software solutions used successfully in over 160 hospital centers in 18 countries around the world.
Ad Statistics
Times Displayed: 50213
Times Visited: 1424 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About UNICANCER
UNICANCER groups together all the French Comprehensive Cancer Centres (FCCCs). These 20 private, non-profit health establishments are exclusively dedicated to care, research and education in cancer. UNICANCER also aims to facilitate the pooling of resources, expertise and best practice between FCCCs in the areas of research, care, hospital management, and procurement. Its mission is to enable FCCCs to stay ahead and innovate together, and always for the benefit of their patients. As a clinical research sponsor, UNICANCER has shored up its position as a major French player in oncology. It is accredited by the Ministry of Health and is eligible for public grants. Its research unit is tasked with implementing UNICANCER’s overall research strategy, which involves promoting access to innovation and improving care for patients with cancer. In 2016, 5,400 patients were included in UNICANCER sponsored clinical trials within 270 healthcare establishments, 20% of which abroad.
The UNICANCER Translational Research and Development in Radiation Oncology (UNITRAD) Group’s goal is to promote innovative and strategic radiotherapy research programmes, and to develop collaborative networks. Its experts work on numerous of topics such as brachytherapy, imaging, modelling and radiomics, radiobiology and radiopotentiation, ionising radiation, quality assurance and methodology. UNICANCER 2016 key figures: 20 healthcare establishments, 19,000 employees, €2.4 billion in revenue, more than 500 ongoing clinical trials, over 135,000 patients hospitalized per year. Financial volume negotiated by UNICANCER purchasing department: 475 million euros per year.
About Paris Région Entreprises
Paris Region Enterprises is the agency in charge of promoting the Paris Region to attract international companies and support them in setting up providing a full range of tailored services, including a dedicated business advisor who enables international investors to:
